To Wipe or Not To Wipe?: That Is The Question
o Wipe or Not To Wipe?: That Is The Question
1 other identifier
interventional
600
1 country
1
Brief Summary
The primary aim of this randomized control trial is to characterize whether a mid-stream clean catch sample using a cleansing wipe in the setting of symptomatic UTI in a female patient is associated with a lower rate of contamination. We hypothesize that using a perineal cleansing wipe at the time of a midstream urine sample will decrease rates of contamination for female patients with a symptomatic UTI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
ExpectedMay 21, 2025
May 1, 2025
2.1 years
February 28, 2024
May 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of Contamination
rate of contamination of midstream clean catch urine samples
1 year
Study Arms (2)
Perineal Wipe
EXPERIMENTALPatient will use wipe before collecting mid-stream clean catch culture
No Wipe
NO INTERVENTIONPatient will not use wipe before collecting mid-stream clean catch culture
Interventions
Eligibility Criteria
You may qualify if:
- adult female patients \>18 who present to the urology clinic at IRL or 3RC with a symptomatic UTI: symptoms include urgency, frequency, urgency urinary incontinence increased from baseline symptoms, dysuria, fevers, flank pain, suprapubic pain/pressure, low back pain, cloudy urine, malodorous urine
You may not qualify if:
- patients who are asymptomatic, have an indwelling catheter, SPT, stent, nephrostomy tube, perform CIC, are on daily antibiotic prophylaxis, or already on existing antibiotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Joanna A. Orzellead
Study Sites (1)
University of Iowa
Iowa City, Iowa, 52242, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna A Orzel
University of Iowa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 6, 2024
Study Start
April 1, 2024
Primary Completion
May 1, 2026
Study Completion (Estimated)
October 1, 2027
Last Updated
May 21, 2025
Record last verified: 2025-05